Search - tctmd.com

Displaying 1 - 20 of 1866

Sort: Relevancy | Date

Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT

News Daily News

Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT

December 15, 2025

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

News Daily News

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

Yael L. Maxwell

December 15, 2025

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

News Daily News

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

December 05, 2025

Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials

News Conference News AHA 2025

Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials

Yael L. Maxwell

November 13, 2025

What’s Going to Be Hot at AHA 2025?

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

October 22, 2025

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

News Daily News

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

October 21, 2025

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

News Conference News EACTS 2025

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

Yael L. Maxwell

October 10, 2025

ACC: It’s Time for Clinicians to Address Inflammation in CVD

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

October 03, 2025

Lactate Clearance May Act as ‘Early Warning Sign’ in Cardiogenic Shock

News Daily News

Lactate Clearance May Act as ‘Early Warning Sign’ in Cardiogenic Shock

September 25, 2025

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

European Experts Provide Advice on Managing CV Effects of COVID-19

News Daily News

European Experts Provide Advice on Managing CV Effects of COVID-19

September 19, 2025

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

ASNC Fighting Back Against Proposed Reimbursement Cuts for Amyloid Imaging

News Daily News

ASNC Fighting Back Against Proposed Reimbursement Cuts for Amyloid Imaging

Yael L. Maxwell

September 11, 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

Home-Based Intervention Drops Blood Pressure in Rural South Africa

News Conference News ESC 2025

Home-Based Intervention Drops Blood Pressure in Rural South Africa

September 04, 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

PREVENT Equations in BP Guidelines Means Better Treatment, the ACC/AHA Say

News Daily News

PREVENT Equations in BP Guidelines Means Better Treatment, the ACC/AHA Say

Yael L. Maxwell

August 28, 2025

TCTMD's Top 10 Most Popular Stories for August 2025

News Opinion Editor's Corner

TCTMD's Top 10 Most Popular Stories for August 2025

August 28, 2025

Evolocumab Gains Expanded Indication for Primary Prevention

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

Michael O'Riordan

August 26, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.